Bekelis Kimon, Marth Nancy J, Wong Kendrew, Zhou Weiping, Birkmeyer John D, Skinner Jonathan
Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire2The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
JAMA Intern Med. 2016 Sep 1;176(9):1361-8. doi: 10.1001/jamainternmed.2016.3919.
Physicians often must decide whether to treat patients with acute stroke locally or refer them to a more distant Primary Stroke Center (PSC). There is little evidence on how much the increased risk of prolonged travel time offsets benefits of a specialized PSC care.
To examine the association of case fatality with receiving care in PSCs vs other hospitals for patients with stroke and to identify whether prolonged travel time offsets the effect of PSCs.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of Medicare beneficiaries with stroke admitted to a hospital between January 1, 2010, and December 31, 2013. Drive times were calculated based on zip code centroids and street-level road network data. We used an instrumental variable analysis based on the differential travel time to PSCs to control for unmeasured confounding. The setting was a 100% sample of Medicare fee-for-service claims.
Admission to a PSC.
Seven-day and 30-day postadmission case-fatality rates.
Among 865 184 elderly patients with stroke (mean age, 78.9 years; 55.5% female), 53.9% were treated in PSCs. We found that admission to PSCs was associated with 1.8% (95% CI, -2.1% to -1.4%) lower 7-day and 1.8% (95% CI, -2.3% to -1.4%) lower 30-day case fatality. Fifty-six patients with stroke needed to be treated in PSCs to save one life at 30 days. Receiving treatment in PSCs was associated with a 30-day survival benefit for patients traveling less than 90 minutes, but traveling at least 90 minutes offset any benefit of PSC care.
Hospitalization of patients with stroke in PSCs was associated with decreased 7-day and 30-day case fatality compared with noncertified hospitals. Traveling at least 90 minutes to receive care offset the 30-day survival benefit of PSC admission.
医生常常必须决定是在当地治疗急性中风患者,还是将他们转诊至距离更远的初级中风中心(PSC)。关于延长的出行时间所增加的风险在多大程度上抵消了专业PSC护理的益处,几乎没有证据。
研究中风患者在PSC接受治疗与在其他医院接受治疗相比的病死率关联,并确定延长的出行时间是否抵消了PSC的影响。
设计、设置和参与者:对2010年1月1日至2013年12月31日期间住院的医疗保险受益中风患者进行回顾性队列研究。行车时间根据邮政编码中心和街道级道路网络数据计算得出。我们使用基于到PSC的差异出行时间的工具变量分析来控制未测量的混杂因素。研究设置为医疗保险按服务付费索赔的100%样本。
入住PSC。
入院后7天和30天的病死率。
在865184名老年中风患者(平均年龄78.9岁;55.5%为女性)中,53.9%在PSC接受治疗。我们发现,入住PSC与7天病死率降低1.8%(95%置信区间,-2.1%至-1.4%)以及30天病死率降低1.8%(95%置信区间,-2.3%至-1.4%)相关。在30天时,需要56名中风患者在PSC接受治疗才能挽救1条生命。对于出行时间少于90分钟的患者,在PSC接受治疗与30天生存获益相关,但出行至少90分钟会抵消PSC护理的任何益处。
与未经认证的医院相比,中风患者在PSC住院与7天和30天病死率降低相关。出行至少90分钟接受治疗会抵消入住PSC的30天生存获益。